The immunobead RT-PCR method, developed here for detecting CTCs expressing EGFR, may provide an important future clinical application for monitoring the efficacy of systemic therapies through the real-time monitoring of EGFR-positive CTCs in cancer patients during their treatment. Here, EGFR is linked to cancer.